Literature DB >> 32338524

Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Intervention.

Michael Megaly1,2, Iosif Xenogiannis1, Nidal Abi Rafeh3, Dimitri Karmpaliotis4, Stephane Rinfret5, Masahisa Yamane6, M Nicholas Burke1, Emmanouil S Brilakis1.   

Abstract

The retrograde approach has increased the success rate of chronic total occlusion percutaneous coronary intervention but has also been associated with a higher risk of complications. The retrograde approach is usually performed in complex lesions, in which the antegrade approach is not feasible or has failed previously. Using a systematic 10-step approach can maximize the likelihood of success and minimize the risks of retrograde chronic total occlusion interventions.

Entities:  

Keywords:  angioplasty, balloon, coronary; chronic total occlusion; percutaneous coronary intervention; retrograde approach; saphenous vein

Mesh:

Year:  2020        PMID: 32338524     DOI: 10.1161/CIRCINTERVENTIONS.119.008900

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  3 in total

1.  The comparison of efficacy and safety between transradial and transfemoral approach for chronic total occlusions intervention: a meta-analysis.

Authors:  Chiung-Jen Wu; Ping-Yen Liu; Wei-Chieh Lee; Po-Jui Wu; Chih-Yuan Fang; Hsiu-Yu Fang
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

2.  Myocardial contrast echocardiographic diagnosis and follow-up of interventricular septal hematoma after retrograde intervention for a chronic total occlusion of a right coronary artery: a case report.

Authors:  Yu Wang; Dunliang Ma; Bin Zhang; Hongwen Fei
Journal:  Cardiovasc Diagn Ther       Date:  2022-04

3.  One 6-F Guiding Catheter and One Microcatheter to Accomplish a Retrograde Chronic Total Occlusion Approach: The "Reverse Tip-In" or "Introspect" Technique.

Authors:  Ata Firouzi; Zahra Hosseini; Ehsan Khalilipur
Journal:  Case Rep Cardiol       Date:  2022-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.